Clinical Trials Logo

Clinical Trial Summary

The study aims to investigate the effect of Permethrin 5% treatment on Signs and symptoms of Demodex-blepharitis in comparison to Synthomycine 5% and Fucithalmic (fusidic acid 1%) .


Clinical Trial Description

3 arms study. 75 patient total, 25 patients in each group.

Group A (study group) patients will apply facially Permethrin 5% every night for 3 months.

Group B patients will apply on the eyelids Fusidic acid 1% every night for 3 months.

Group C patients will apply on the eyelids Synthomycine 5% every night for 3 months

Follow up Evaluation will be made after one week, one month, two months, three months, 4 months and half a year. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03105505
Study type Interventional
Source Barzilai Medical Center
Contact
Status Enrolling by invitation
Phase Phase 4
Start date April 28, 2017
Completion date September 2018